GCP
DCPH

GSA Capital Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

GSA Capital Partners’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-52,119
Closed -$820K – 2126
2024
Q1 		$820K Sell
52,119
-80,011
-61% -$1.23M 0.07% 577
2023
Q4 		$2.13M Sell
132,130
-30,569
-19% -$390K 0.18% 101
2023
Q3 		$2.07M Buy
162,699
+42,604
+35% +$588K 0.18% 102
2023
Q2 		$1.69M Buy
120,095
+17,864
+17% +$256K 0.17% 101
2023
Q1 		$1.58M Buy
102,231
+33,942
+50% +$567K 0.16% 129
2022
Q4 		$1.12M Buy
68,289
+54,042
+379% +$879K 0.14% 169
2022
Q3 		$264K Sell
14,247
-10,676
-43% -$168K 0.04% 1018
2022
Q2 		$328K Buy
24,923
+6,210
+33% +$68.5K 0.05% 769
2022
Q1 		$173K Buy
18,713
+3,325
+22% +$28.3K 0.02% 1207
2021
Q4 		$150K Sell
15,388
-45,162
-75% -$849K 0.02% 1271
2021
Q3 		$2.06M Buy
+60,550
New +$1.93M 0.21% 55
2021
Q1 		– Sell
-4,890
Closed -$279K – 1576
2020
Q4 		$279K Buy
+4,890
New +$290K 0.05% 780
2020
Q2 		– Sell
-9,548
Closed -$393K – 1214
2020
Q1 		$393K Buy
+9,548
New +$530K 0.1% 295

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GSA Capital Partners's DCPH Position: Q2 2024 in Review

GSA Capital Partners sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 52,119 shares — an estimated $820K sold.

GSA Capital Partners first reported a position in DCPH in Q1 2020 and held it in 13 quarters. The position peaked at $2.13M in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • GSA Capital Partners reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • GSA Capital Partners sold 52,119 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $820K.
  • GSA Capital Partners first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 13 quarters.
  • GSA Capital Partners's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.13M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.